(Q43203214)

English

Front-line high-dose chemotherapy with rituximab showed excellent long-term survival in adults with aggressive large b-cell lymphoma: final results of a Phase II GOELAMS Study

scientific article published on 4 January 2010

Statements

Front-line high-dose chemotherapy with rituximab showed excellent long-term survival in adults with aggressive large b-cell lymphoma: final results of a Phase II GOELAMS Study (English)
0 references
Marie-Sarah Dilhuydy
Charles Foussard
Philippe Casassus
Christine Le Maignan
Groupe Ouest-Est des Leucémies et Autres Maladies du Sang (GOELAMS)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit